OpenLegislation

Division 10.3 Consideration may be given to the issuing/renewal of group 2 licences to drivers with diabetes mellitus. When treated with medication which carries a risk of inducing hypoglycaemia (that is, with insulin, and some tablets), the following criteria should apply:F1

United Kingdom

Original text. Later amendments are not shown.

  • no severe hypoglycaemic events have occurred in the previous 12 months,

  • the driver has full hypoglycaemic awareness,

  • the driver must show adequate control of the condition by regular blood glucose monitoring, at least twice daily and at times relevant to driving,

  • the driver must demonstrate an understanding of the risks of hypoglycaemia,

  • there are no other debarring complications of diabetes.

Moreover, in these cases, such licences should be issued subject to the opinion of a competent medical authority and to regular medical review, undertaken at intervals of not more than three years.

Annotations

Textual amendments

F1

Substituted by Commission Directive 2009/113/EC of 25 August 2009 amending Directive 2006/126/EC of the European Parliament and of the Council on driving licences.